{
    "type": "ETF",
    "ucits": true,
    "fund_name": "Amundi German Bund Daily (-2x) Inverse UCITS ETF Acc",
    "investment_objective": "To obtain an inverse exposure with a x2 daily leverage to the daily performance of the German government bonds market (8.5 to 10.5 years maturity) by replicating the Solactive Bund Daily (-2x) Inverse Index.",
    "primary_asset_class": "Bond",
    "geographic_focus": "Germany / Eurozone",
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": true,
    "inverse": true,
    "complex_factors": [
        "Synthetic replication via OTC total return swaps",
        "Leverage of 2x inverse exposure",
        "Use of derivatives for daily leveraged inverse strategy",
        "Counterparty risk from swap counterparties",
        "Roll costs and contango effects from futures in benchmark index",
        "Complex index construction with daily leverage reset"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication through OTC total return swaps to achieve a leveraged (-2x) inverse exposure to German government bonds, specifically tracking the Solactive Bund Daily (-2x) Inverse Index. The fund explicitly states use of derivatives and swaps, with counterparty risk capped at 10% per counterparty. The leverage factor is 2x inverse, which is a complexity trigger. The benchmark index involves daily rebalancing and roll costs related to futures contracts, which add complexity and tracking error risk. The risk profile is medium-high (5/7), reflecting leverage and derivative use. The PRIIPs KID confirms the product is intended for investors with some experience and warns about potential losses of the full investment. The factsheet confirms synthetic replication and leverage, and the use of swaps to avoid cash borrowing costs. These factors combined meet MiFID II criteria for a complex financial instrument due to leverage, synthetic replication, derivative use, and counterparty risk exposure. Although it is UCITS compliant, the product's structure and strategy complexity classify it as complex under MiFID II.",
    "risk_level_assessment": "The fund's stated risk level is 5 out of 7, indicating medium-high risk consistent with leveraged inverse bond exposure and derivative use. This aligns with the complexity classification, as the product carries significant market, leverage, and counterparty risks that may not be easily understood by retail investors."
}